247 related articles for article (PubMed ID: 30962859)
1. Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literature.
Suarez-Kelly LP; Yu L; Kline D; Schneider EB; Agnese DM; Carson WE
Hered Cancer Clin Pract; 2019; 17():12. PubMed ID: 30962859
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer risk in neurofibromatosis type 1 is a function of the type of
Frayling IM; Mautner VF; van Minkelen R; Kallionpaa RA; Aktaş S; Baralle D; Ben-Shachar S; Callaway A; Cox H; Eccles DM; Ferkal S; LaDuca H; Lázaro C; Rogers MT; Stuenkel AJ; Summerour P; Varan A; Yap YS; Zehou O; Peltonen J; Evans DG; Wolkenstein P; Upadhyaya M
J Med Genet; 2019 Apr; 56(4):209-219. PubMed ID: 30530636
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of breast cancer in women with NF1.
Madanikia SA; Bergner A; Ye X; Blakeley JO
Am J Med Genet A; 2012 Dec; 158A(12):3056-60. PubMed ID: 23165953
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study.
Evans DGR; Kallionpää RA; Clementi M; Trevisson E; Mautner VF; Howell SJ; Lewis L; Zehou O; Peltonen S; Brunello A; Harkness EF; Wolkenstein P; Peltonen J
Genet Med; 2020 Feb; 22(2):398-406. PubMed ID: 31495828
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer and other neoplasms in women with neurofibromatosis type 1: a retrospective review of cases in the Detroit metropolitan area.
Wang X; Levin AM; Smolinski SE; Vigneau FD; Levin NK; Tainsky MA
Am J Med Genet A; 2012 Dec; 158A(12):3061-4. PubMed ID: 22965642
[TBL] [Abstract][Full Text] [Related]
6. Beliefs, screening attitudes and breast cancer awareness of young women with neurofibromatosis type 1: A reflexive thematic analysis.
Plunkett C; Pilkington M
J Health Psychol; 2024 Jun; ():13591053241255053. PubMed ID: 38859614
[TBL] [Abstract][Full Text] [Related]
7. Breast density in NF1 women: a retrospective study.
De Santis R; Cagnoli G; Rinaldi B; Consonni D; Conti B; Eoli M; Liguori A; Cosentino M; Carrafiello G; Garrone O; Giroda M; Cesaretti C; Sfondrini MS; Gambini D; Natacci F
Fam Cancer; 2024 Mar; 23(1):35-40. PubMed ID: 38270845
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype.
Yap YS; Munusamy P; Lim C; Chan CHT; Prawira A; Loke SY; Lim SH; Ong KW; Yong WS; Ng SBH; Tan IBH; Callen DF; Lim JCT; Thike AA; Tan PH; Lee ASG
Breast Cancer Res Treat; 2018 Oct; 171(3):719-735. PubMed ID: 29926297
[TBL] [Abstract][Full Text] [Related]
9. Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening.
Sharif S; Moran A; Huson SM; Iddenden R; Shenton A; Howard E; Evans DG
J Med Genet; 2007 Aug; 44(8):481-4. PubMed ID: 17369502
[TBL] [Abstract][Full Text] [Related]
10. Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1.
Uusitalo E; Rantanen M; Kallionpää RA; Pöyhönen M; Leppävirta J; Ylä-Outinen H; Riccardi VM; Pukkala E; Pitkäniemi J; Peltonen S; Peltonen J
J Clin Oncol; 2016 Jun; 34(17):1978-86. PubMed ID: 26926675
[TBL] [Abstract][Full Text] [Related]
11. The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1.
Crook A; Kwa R; Ephraums S; Wilding M; Thiyagarajan L; Fleming J; Moore K; Berman Y
Fam Cancer; 2022 Apr; 21(2):241-253. PubMed ID: 33963463
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience.
Cortesi L; Turchetti D; Marchi I; Fracca A; Canossi B; Rachele B; Silvia R; Rita PA; Pietro T; Massimo F
BMC Cancer; 2006 Aug; 6():210. PubMed ID: 16916448
[TBL] [Abstract][Full Text] [Related]
13. NF1 Patients Receiving Breast Cancer Screening: Insights from The Ontario High Risk Breast Screening Program.
Maani N; Westergard S; Yang J; Scaranelo AM; Telesca S; Thain E; Schachter NF; McCuaig JM; Kim RH
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31121919
[TBL] [Abstract][Full Text] [Related]
14. Early-Onset Breast Cancer in a Family with Neurofibromatosis Type 1 Associated with a Germline Mutation in BRCA1.
Jeon YW; Kim RM; Lim ST; Choi HJ; Suh YJ
J Breast Cancer; 2015 Mar; 18(1):97-100. PubMed ID: 25834617
[TBL] [Abstract][Full Text] [Related]
15. Incidence and prevalence of neurofibromatosis type 1 and 2: a systematic review and meta-analysis.
Lee TJ; Chopra M; Kim RH; Parkin PC; Barnett-Tapia C
Orphanet J Rare Dis; 2023 Sep; 18(1):292. PubMed ID: 37710322
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
17. In-Hospital Clinical Features, Morbidity, and Mortality of Patients with Neurofibromatosis 1 in France: A Nationwide, Population-Based Retrospective Cohort Study.
Diaz E; Bergqvist C; Peiffer B; Fertitta L; Jannic A; Ferkal S; Zehou O; Hemery F; Sbidian E; Wolkenstein P
J Invest Dermatol; 2023 Dec; 143(12):2408-2415.e7. PubMed ID: 37257636
[TBL] [Abstract][Full Text] [Related]
18. Pediatric malignancies in neurofibromatosis type 1: A population-based cohort study.
Peltonen S; Kallionpää RA; Rantanen M; Uusitalo E; Lähteenmäki PM; Pöyhönen M; Pitkäniemi J; Peltonen J
Int J Cancer; 2019 Dec; 145(11):2926-2932. PubMed ID: 30724342
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
